Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.42 USD | -26.21% | -4.79% | +21.37% |
04-15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
04-15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |